$PLTR 20250829 150.0 PUT$ PLTR: collect $138 (0.9%) premium on this short put with strike at $150. Contract expires next Fri on 29th Aug. PLTR rebounded on Fri and closed at $158.74. About 17% down from its recent high, I think the pullback will be shallow and PLTR might still consolidate for a while waiting for earnings to catch up in coming months.
$GOOG DIAGONAL 250822/250905 CALL 192.5/CALL 195.0$ GOOG: losing trade management. The expiring short call at $192.5 will end up in the money on 22nd Aug. Decided to pay small debit to roll this higher to $195 strike and also further by 2 weeks to 5th Sept. New strike is still in the money, so will depend if price will retrace. Else, will close this losing trade and offset by the profitable long call so that can reset new trade with revised setup.
1. $S&P 500(.SPX)$ TRADE PLAN 📈 📉 SPX bullish plan: SPX above 6469 | SPX Aug 27 6500C T 6500,6525 SL 6369 📈SPX bearish plan: SPX under 6427 | SPX Aug 27 6380P T 6400,6369 SL 6468 📉 SPX broke out above 6400 on Friday and ran to 6478. If SPX can get through 6500 we can see 6528,6559 next. Calls can work above 6468 as a lotto. Calls can also work above 6500 this week. If SPX fails at 6427 I’d consider puts for a move to 6400.Image2. $Strategy(MSTR)$ Trade Idea: Aug 29 370C Trigger: 354 ✅Targets: 363, 380 🎯Stop: 342 🛑 After a 7 week pull back, MSTR started to show some signs of life this past week. MSTR dropped to 324 and touched 359 at the highs by Friday. MSTR through 363 can test 380-390 this week. We
🎁Capturing Top 10 Ex_dividend: LYB, JNJ, SPGI, ATO, WILC...
1.Which High Ex-dividend Stock (on 25 August ~ 29 August) do You Like the Most?Be Sure To Check Out the Last Chance to Buy the Top 10 High dividend stocks going to Ex-dividends This Week: many companies like $LYB$ and $JNJ$ showing below are about to give decent dividends into "your pocket".Editor's notes:A dividend-paying stock ex-dividend date, or ex-date, is very important to investors. In a nutshell, if you buy a dividend stock before the ex-dividend date, then you will receive the next upcoming dividend payment.If you purchase the stock on or after the ex-dividend date, you will not receive the dividend. Some investors utilize strategies whereby they will purchase stocks just prior to an ex-dividend date and sell shortly thereafter.2.YTD25 of the Above 10 Stocks are as Below:TradingVi
$UnitedHealth(UNH)$ I would never have expected this. Warren Buffett just added about 5 million shares to UnitedHealth Group to bring his stakes’ worth to US$1.6 billion.We all remember what happened to its ex-CEO, Brian Thompson, and the social media firestorm that came with it.But Warren Buffett might have seen something worth considering.Firstly, UnitedHealth’s valuation is very cheap now. It is trading at a price-to-earnings ratio of 12.9 times compared to its historical average of 26.2 times.Share price has also dropped to a low of US$234 in July 2025, before news of Buffett’s purchase of the company’s share sent the stock flying to US$304 recently.Secondly, despite the social media firestorm, UnitedHealth’s revenue did grow by 9.8% and 12.9%
Hello everyone! Today i want to share some trading ideas with you!1.Trading is a mirror. $Cboe Volatility Index(VIX)$ It reflects your discipline, patience, biases, and fears back at you. Markets don’t lie; they expose weaknesses ruthlessly. The trader who grows is the one who uses every loss as feedback, not as punishment.2.Most traders obsess over being right. The real pros obsess over staying solvent. Accuracy means little if drawdowns kill your ability to continue. The name of the game is survival first, profits second.3.Conviction without risk control is gambling. Risk control without conviction is paralysis. You need both: belief in your edge and humility to cap downside. One keeps you in trades long enough to win; the other ensures losses ne
BN will be One of the Biggest Beneficiaries of the Fed’s Dovish Pivot
$Brookfield Corp(BN)$ will be one of the biggest beneficiaries of the Fed’s dovish pivot.Investors will have to allocate capital but the public equities are already overvalued.Where will the money go?- Credit- Infrastructure- Private Equity- Energy investmentsCredit and PE are the natural destinations. Infrastructure and energy are the up and coming trends driven by AI boom. $Brookfield Corp(BN)$ is active in all these areas, it’s the the largest alternative investment manager in the world.It aims to double fee bearing capital in the next 5 years.Given the tailwinds, it can do it way faster.Long BN.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,
Fed is preparing to cut rates-- Which stocks Benefit from it?
Fed is preparing to cut rates.Two group of companies will heavily benefit from the weaker USD.LatAm neo-banks listed in the US:- $Nu Holdings Ltd.(NU)$ - $Inter & Co Inc(INTR)$ Sub-prime lenders and BNPL players:- $OppFi Inc.(OPFI)$ - $Sezzle Inc(SEZL)$ - $Affirm Holdings, Inc.(AFRM)$ They are set to outperform in the next couple of years.For whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here:
WHY PLTR VALUATION ACTUALLY ISN'T AS EXPENSIVE AS YOU THINK
$Palantir Technologies Inc.(PLTR)$ Everyone loves to scream Palantir is expensive -- but that’s just lazy. If all you’re doing is looking at P/S or headline multiples, of course it looks stretched. Spend five minutes on the fundamentals and the story flips.Earnings are growing twice as fast as revenue -- which is why PEG matters. Palantir (1.6x) is priced no differently than $CRM (1.5x). The difference? Salesforce faces AI disruption, while Palantir already has the platform built for it. That’s why the Citron short reports was outright idiotic -- they’re looking through an outdated SaaS lens. Palantir isn’t selling software seats or dashboards. It’s embedding itself into the operational core of the digital economy, where AI isn’t just a tool but t
Please do your own research "Wall Street remains highly optimistic heading into Nvidia’s upcoming earnings report. Analysts forecast adjusted EPS around $1.02 and revenue surging over 50% year-over-year, around $46.45 billion . • Although export restrictions to China may cost Nvidia several billion dollars, a 15% revenue-sharing deal for H20 chip sales could provide relief . • Market confidence is supported by bullish price targets many above $200, some even up to $225 and nearly all surveyed analysts rate NVDA a “buy” . • Citi recently raised its price target to $190, citing surging demand in the sovereign AI space, where Nvidia is deeply involved . • That said, concerns persist: valuations are elevated (trading at 36–56× forward earnings), and China restrictions, along with any AI valuat